+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Radiopharmaceuticals Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

  • ID: 4829949
  • Report
  • Region: Global
  • 158 pages
  • 360iResearch
1 of 3

FEATURED COMPANIES

  • Bayer AG
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • Curium France SASU
  • GE Healthcare Inc
  • Jubilant Pharma. LLC
  • MORE
The Global Radiopharmaceuticals Market is expected to grow from USD 3952.56 Millions in 2018 to USD 5986.46 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.10%.

Increasing incidence and prevalence of target conditions is one of the factors largely attributing to the growth of the Global Radiopharmaceuticals Market

The factors attributing to the growth of the market are Initiatives to reduce the demand-supply gap of mo-99, Alpha radioimmunotherapy-based targeted cancer treatment, and Increasing incidence and prevalence of target conditions. However, some factors such as Shorter life of radiopharmaceuticals may hinder the market growth. The Global Radiopharmaceuticals Market is expected to showcase the opportunities such as Adoption of radiopharmaceuticals in neurological applications. In the near future market may face the possible challenges in the growth due to High equipment prices lead to reduced hospital budget. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Global Radiopharmaceuticals Market.

On the basis of Type, the Global Radiopharmaceuticals Market is studied across Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine.

On the basis of Procedural Volume, the Global Radiopharmaceuticals Market is studied across Diagnostic Procedures and Therapeutic Procedures.

On the basis of Application, the Global Radiopharmaceuticals Market is studied across Diagnostic Applications and Therapeutic Applications.

Bayer AG the potential growing player for the Global Radiopharmaceuticals Market

The key players profiled in the Global Radiopharmaceuticals Market are Bayer AG, Eczacibasi-Monrol Nuclear Products Co., GE Healthcare Inc, Bracco Imaging SpA, Sigma- Aldrich Corporation, Mallinckrodt PLC, Medtronic PLC, Advanced Accelerator Applications S.A, Curium France SASU, Lantheus Medical Imaging, Inc., Nordion Inc., Cardinal Health, Inc., Siemens Healthineers AG, and Jubilant Pharma. LLC.

The report covers two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

The market forecasting is based on a market model
derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Radiopharmaceuticals Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Radiopharmaceuticals Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Radiopharmaceuticals Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Radiopharmaceuticals Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Radiopharmaceuticals Market

The report answers questions such as:

1. What is the market size of Radiopharmaceuticals market in the Global?
2. What are the factors that affect the growth in the Global Radiopharmaceuticals Market over the forecast period?
3. What is the competitive position in the Global Radiopharmaceuticals Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Radiopharmaceuticals Market?
5. What are the opportunities in the Global Radiopharmaceuticals Market?
6. What are the modes of entering the Global Radiopharmaceuticals Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bayer AG
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • Curium France SASU
  • GE Healthcare Inc
  • Jubilant Pharma. LLC
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. FPNV Positioning Matrix
2.3.2.1. Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support

3. Executive Summary
3.1. Outlook in the Radiopharmaceuticals Market
3.2. Opportunities in the Radiopharmaceuticals Market
3.3. Geographical Analysis in the Radiopharmaceuticals Market

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing incidence and prevalence of target conditions
4.2.1.2. Alpha radioimmunotherapy-based targeted cancer treatment
4.2.1.3. Initiatives to reduce the demand-supply gap of mo-99
4.2.2. Restraints
4.2.2.1. Shorter life of radiopharmaceuticals
4.2.3. Opportunities
4.2.3.1. Adoption of radiopharmaceuticals in neurological applications
4.2.4. Challenges
4.2.4.1. High equipment prices lead to reduced hospital budget
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends

5. Global Radiopharmaceuticals Market, by Type
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Diagnostic Nuclear Medicine
5.3.1. Pet Radiopharmaceuticals
5.3.1.1. F-18
5.3.1.2. Ru-82
5.3.2. Spect Radiopharmaceuticals
5.3.2.1. Ga-67
5.3.2.2. I-123
5.3.2.3. Tc-99m
5.3.2.4. Tl-201
5.4. Therapeutic Nuclear Medicine
5.4.1. Alpha Emitters
5.4.1.1. Ra-223
5.4.2. Beta Emitters
5.4.2.1. I-131
5.4.2.2. Lu-177
5.4.2.3. Re-186
5.4.2.4. Sm-153
5.4.2.5. Y-90
5.4.3. Brachytherapy Isotopes
5.4.3.1. Cs-131
5.4.3.2. I-125
5.4.3.3. Ir-192
5.4.3.4. Pd-103

6. Global Radiopharmaceuticals Market, by Procedural Volume
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Diagnostic Procedures
6.3.1. Pet Radiopharmaceuticals
6.3.2. Spect Radiopharmaceuticals
6.4. Therapeutic Procedures
6.4.1. Alpha Emitters
6.4.2. Beta Emitters
6.4.3. Brachytherapy Isotopes

7. Global Radiopharmaceuticals Market, by Application
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Diagnostic Applications
7.3.1. Pet Applications
7.3.1.1. Cardiology
7.3.1.2. Neurology
7.3.1.3. Oncology
7.3.2. Spect Applications
7.3.2.1. Cardiology
7.3.2.2. Lymphoma
7.3.2.3. Neurology
7.3.2.4. Thyroid
7.4. Therapeutic Applications
7.4.1. Bone Metastasis
7.4.2. Endocrine Tumors
7.4.3. Lymphoma
7.4.4. Thyroid

8. Americas Radiopharmaceuticals Market Estimates & Trend Analysis
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Canada
8.4. Mexico
8.5. United States

9. Asia-Pacific Radiopharmaceuticals Market Estimates & Trend Analysis
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. China
9.4. India
9.5. Japan

10. Europe, Middle East & Africa Radiopharmaceuticals Market Estimates & Trend Analysis
10.1. Overview
10.2. Market Sizing & Forecasting
10.3. France
10.4. Germany
10.5. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix for Global Radiopharmaceuticals Market
11.2. Market Vendor Ranking Analysis for Global Radiopharmaceuticals Market
11.3. Competitive News Feed Analysis for Global Radiopharmaceuticals Market
11.3.1. Mergers & Acquisitions
11.3.2. New Product Launches
11.3.3. Business Expansions
11.3.4. Partnerships, Agreements & Collaborations

12. Company Usability Profiles
12.1. Bayer AG
12.1.1. Overview
12.1.2. Strategy
12.1.3. SWOT
12.1.4. Scorecard
12.2. Cardinal Health, Inc.
12.2.1. Overview
12.2.2. Strategy
12.2.3. SWOT
12.2.4. Scorecard
12.3. Curium France SASU
12.3.1. Overview
12.3.2. Strategy
12.3.3. SWOT
12.3.4. Scorecard
12.4. GE Healthcare Inc
12.4.1. Overview
12.4.2. Strategy
12.4.3. SWOT
12.4.4. Scorecard
12.5. Lantheus Medical Imaging, Inc.
12.5.1. Overview
12.5.2. Strategy
12.5.3. SWOT
12.5.4. Scorecard
12.6. Advanced Accelerator Applications S.A
12.6.1. Overview
12.6.2. Strategy
12.6.3. SWOT
12.6.4. Scorecard
12.7. Bracco Imaging SpA
12.7.1. Overview
12.7.2. Strategy
12.7.3. SWOT
12.7.4. Scorecard
12.8. Eczacibasi-Monrol Nuclear Products Co.
12.8.1. Overview
12.8.2. Strategy
12.8.3. SWOT
12.8.4. Scorecard
12.9. Jubilant Pharma. LLC
12.9.1. Overview
12.9.2. Strategy
12.9.3. SWOT
12.9.4. Scorecard
12.10. Mallinckrodt PLC
12.10.1. Overview
12.10.2. Strategy
12.10.3. SWOT
12.10.4. Scorecard
12.11. Medtronic PLC
12.11.1. Overview
12.11.2. Strategy
12.11.3. SWOT
12.11.4. Scorecard
12.12. Nordion Inc.
12.12.1. Overview
12.12.2. Strategy
12.12.3. SWOT
12.12.4. Scorecard
12.13. Siemens Healthineers AG
12.13.1. Overview
12.13.2. Strategy
12.13.3. SWOT
12.13.4. Scorecard
12.14. Sigma- Aldrich Corporation
12.14.1. Overview
12.14.2. Strategy
12.14.3. SWOT
12.14.4. Scorecard

13. Appendix
13.1. Discussion Guide
13.2. Top Reports
13.2.1. Global Gastrointestinal Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.2. Global Polymer Matrix Composites Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.3. Global Policy Management Software Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.4. Global Smart Waste Management Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.3. Author Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bayer AG
  • Cardinal Health, Inc.
  • Curium France SASU
  • GE Healthcare Inc
  • Lantheus Medical Imaging, Inc.
  • Advanced Accelerator Applications S.A
  • Bracco Imaging SpA
  • Eczacibasi-Monrol Nuclear Products Co.
  • Jubilant Pharma. LLC
  • Mallinckrodt PLC
  • Medtronic PLC
  • Nordion Inc.
  • Siemens Healthineers AG
  • Sigma- Aldrich Corporation
Note: Product cover images may vary from those shown
Adroll
adroll